ICER methods could be illegal in US, claims US think tankThe method used by the US Institute for Clinical and Economic Review (ICER) to gauge whether drugs are Share XICER methods could be illegal in US, claims US think tankhttps://pharmaphorum.com/news/icer-methods-could-be-illegal-in-us-claims-us-think-tank/
Collaboration can ensure access to life-changing innovationAs a pioneering risk sharing scheme has shown, new medications can be the catalyst for a whole new Share XCollaboration can ensure access to life-changing innovationhttps://pharmaphorum.com/views-analysis-market-access/access-life-changing-innovation-risk-sharing-scheme/
Orphan medicines, advances, access and affordabilityLONDON, UNITED KINGDOM, April 19th 2017: The number of orphan drug candidates gaining European market authorisation has risen Share XOrphan medicines, advances, access and affordabilityhttps://pharmaphorum.com/partner-content-market-access/orphan-medicines-advances-access-affordability/
